WO1997030736A3 - Milieu de contraste - Google Patents

Milieu de contraste Download PDF

Info

Publication number
WO1997030736A3
WO1997030736A3 PCT/GB1997/000473 GB9700473W WO9730736A3 WO 1997030736 A3 WO1997030736 A3 WO 1997030736A3 GB 9700473 W GB9700473 W GB 9700473W WO 9730736 A3 WO9730736 A3 WO 9730736A3
Authority
WO
WIPO (PCT)
Prior art keywords
contrast medium
contrast
agent
modifier
medium
Prior art date
Application number
PCT/GB1997/000473
Other languages
English (en)
Other versions
WO1997030736A2 (fr
Inventor
Natarajan Rajagopalan
Kevin Darryl Ostrander
Evan Gustow
Brian Doty
Phillip Harnish
Original Assignee
Nycomed Imaging As
Cockbain Julian
Natarajan Rajagopalan
Kevin Darryl Ostrander
Evan Gustow
Brian Doty
Phillip Harnish
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As, Cockbain Julian, Natarajan Rajagopalan, Kevin Darryl Ostrander, Evan Gustow, Brian Doty, Phillip Harnish filed Critical Nycomed Imaging As
Priority to JP9529894A priority Critical patent/JP2000504742A/ja
Priority to BR9710946-0A priority patent/BR9710946A/pt
Priority to EP97905227A priority patent/EP0881916A2/fr
Priority to AU18852/97A priority patent/AU1885297A/en
Publication of WO1997030736A2 publication Critical patent/WO1997030736A2/fr
Publication of WO1997030736A3 publication Critical patent/WO1997030736A3/fr
Priority to NO983828A priority patent/NO983828L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0404X-ray contrast preparations containing barium sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806Suspensions, emulsions, colloids, dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/226Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne un milieu de contraste, capable de bien se déposer sur la partie inférieure du tube digestif, après une administration par voie orale. Le milieu comprend une quantité suffisante d'agent de contraste pour pouvoir effectuer les diagnostics requis, en combinaison avec un modificateur de viscosité et un modificateur osmotique, ces deux modificateurs étant présents tous deux en une proportion pondérale par rapport audit agent d'au moins 1:20.
PCT/GB1997/000473 1996-02-20 1997-02-20 Milieu de contraste WO1997030736A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP9529894A JP2000504742A (ja) 1996-02-20 1997-02-20 コントラスト媒体
BR9710946-0A BR9710946A (pt) 1996-02-20 1997-02-20 Meio de contraste
EP97905227A EP0881916A2 (fr) 1996-02-20 1997-02-20 Milieu de contraste
AU18852/97A AU1885297A (en) 1996-02-20 1997-03-20 Contrast medium
NO983828A NO983828L (no) 1996-02-20 1998-08-20 Kontrastmiddel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9603547.2 1996-02-20
GBGB9603547.2A GB9603547D0 (en) 1996-02-20 1996-02-20 Contrast media

Publications (2)

Publication Number Publication Date
WO1997030736A2 WO1997030736A2 (fr) 1997-08-28
WO1997030736A3 true WO1997030736A3 (fr) 1997-12-18

Family

ID=10789076

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/000473 WO1997030736A2 (fr) 1996-02-20 1997-02-20 Milieu de contraste

Country Status (11)

Country Link
EP (1) EP0881916A2 (fr)
JP (1) JP2000504742A (fr)
KR (1) KR19990087196A (fr)
CN (1) CN1215342A (fr)
AU (1) AU1885297A (fr)
BR (1) BR9710946A (fr)
CA (1) CA2247041A1 (fr)
GB (1) GB9603547D0 (fr)
HU (1) HUP9901323A2 (fr)
NO (1) NO983828L (fr)
WO (1) WO1997030736A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6928314B1 (en) 1998-01-23 2005-08-09 Mayo Foundation For Medical Education And Research System for two-dimensional and three-dimensional imaging of tubular structures in the human body
DE19844495B4 (de) * 1998-09-29 2005-04-07 Man Roland Druckmaschinen Ag Verfahren zur Farbkalibrierung mittels Colormanagement für eine digital ansteuerbare Druckmaschine mit einer wiederbeschreibbaren Druckform
JP3461750B2 (ja) 1999-03-04 2003-10-27 パナソニック コミュニケーションズ株式会社 通信装置、通信方法、および発信者情報の登録方法
US7591998B2 (en) 2000-03-07 2009-09-22 Kevin Tait Stool marker
AUPQ605500A0 (en) 2000-03-07 2000-03-30 Medefield Pty Ltd Stool marker
US6477401B1 (en) * 2000-03-10 2002-11-05 Mayo Foundation For Medical Education And Research Colonography of an unprepared colon
US8031921B2 (en) 2005-02-14 2011-10-04 Mayo Foundation For Medical Education And Research Electronic stool subtraction in CT colonography
WO2008134633A1 (fr) * 2007-04-27 2008-11-06 Pluromed, Inc. Échographie utilisant des gels de couplage dont l'adhésion varie en fonction de la sensibilité au temps et à la température
CN105142680A (zh) 2013-03-15 2015-12-09 加利福尼亚大学董事会 基于低-z原子的肠ct造影材料
CN105848582A (zh) 2013-08-16 2016-08-10 加利福尼亚大学董事会 硅酮基肠道ct对比材料
CN104587494A (zh) * 2014-12-19 2015-05-06 张锐 一种胃肠钡餐造影配方及其制备方法
WO2017059092A1 (fr) 2015-09-30 2017-04-06 Duke University Formulations d'ascorbate et méthodes d'utilisation en tant qu'agents de contraste
CN106075476B (zh) * 2016-07-30 2019-05-31 温州市人民医院 一种造影剂
US20210186819A1 (en) * 2018-09-07 2021-06-24 Moore Dental Technologies And Solutions Llc Dental Fracture Detection Compositions and Methods
CN109540936A (zh) * 2019-01-11 2019-03-29 大连大学附属中山医院 一种用于高分辨率ct及x线动脉、静脉或管道的室温造影剂及其制备方法
CN117503959B (zh) * 2023-08-30 2024-07-09 吉锐威(北京)科技有限公司 一种基于硅酸镁铝和微晶纤维素的即用液态型口服胃超声显影剂配方及制作方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980001244A1 (fr) * 1978-12-19 1980-06-26 Bykgulden Lomberg Chem Fab Solutions pour milieux de contraste pour rayons x
WO1991001147A1 (fr) * 1989-07-21 1991-02-07 Nycomed As Milieux de contraste particulaires
EP0498482A2 (fr) * 1991-01-25 1992-08-12 NanoSystems L.L.C. Agents de contraste pour application en imagerie médicale
EP0605024A2 (fr) * 1992-12-16 1994-07-06 NanoSystems L.L.C. Emploi de modificateurs de surface purifiés pour éviter l'agrégation de particules pendant la stérilisation
WO1995022995A1 (fr) * 1994-02-25 1995-08-31 Nycomed Imaging A/S Compositions de contraste radiologique contenant des derives de la cellulose

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980001244A1 (fr) * 1978-12-19 1980-06-26 Bykgulden Lomberg Chem Fab Solutions pour milieux de contraste pour rayons x
WO1991001147A1 (fr) * 1989-07-21 1991-02-07 Nycomed As Milieux de contraste particulaires
EP0498482A2 (fr) * 1991-01-25 1992-08-12 NanoSystems L.L.C. Agents de contraste pour application en imagerie médicale
EP0605024A2 (fr) * 1992-12-16 1994-07-06 NanoSystems L.L.C. Emploi de modificateurs de surface purifiés pour éviter l'agrégation de particules pendant la stérilisation
WO1995022995A1 (fr) * 1994-02-25 1995-08-31 Nycomed Imaging A/S Compositions de contraste radiologique contenant des derives de la cellulose

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 72, no. 24, 15 June 1970, Columbus, Ohio, US; abstract no. 125083, ALPIN, ALBERT ET AL: "X-ray contrast preparations" XP002044418 *

Also Published As

Publication number Publication date
KR19990087196A (ko) 1999-12-15
CN1215342A (zh) 1999-04-28
EP0881916A2 (fr) 1998-12-09
NO983828L (no) 1998-10-15
CA2247041A1 (fr) 1997-08-28
HUP9901323A2 (hu) 1999-08-30
BR9710946A (pt) 2000-10-31
WO1997030736A2 (fr) 1997-08-28
JP2000504742A (ja) 2000-04-18
GB9603547D0 (en) 1996-04-17
NO983828D0 (no) 1998-08-20
AU1885297A (en) 1997-09-10

Similar Documents

Publication Publication Date Title
WO1997030736A3 (fr) Milieu de contraste
ZA959853B (en) Lubricating composition including an ester - use of the composition and well fluid including the composition.
ZA9610429B (en) Coating composition having anti-reflective and anti-fogging properties.
CA2222676A1 (fr) Nouvelle composition pharmaceutique possedant un effet anesthesique
AU3865595A (en) Inorganic resin compositions, their preparation and use thereof
TR199700049A2 (tr) Düsük CO'lu sigara.
CA2163837A1 (fr) Hydrates de paclitaxel cristallises
NZ526266A (en) Paper coating composition that contains between 0.01 and 100 weight %, relative to the solid weight, of a condensation polymer and has a low viscosity
ZA986421B (en) 2-[Pyrazolyl-and triazolyl-3'-oxymethylene]phenylisoxa zolones, -triazolones and - tetrazolones, their preparation and their use.
EP1011029A3 (fr) Composition de résine photosensible
CA2319541A1 (fr) Melanges de fibres de verre doubles, demelables par cardage
CA2221011A1 (fr) Agent de nettoyage intestinal a base de phosphate de sodium enrobe
CA2298635A1 (fr) Polyols de polysiloxane
AU2639299A (en) Remedies/preventives for parkinson's disease
CA2095721A1 (fr) Compositions sous forme de gels pour soin de peaux grasses
HK1052723A1 (en) Lubricating oil compatibility improver and lubricating oil composition comprising the improver.
AU7624598A (en) 1,4-diazabicyclo (2.2.2) Oct-2-ylmethyl derivatives, their preparation and the rapeutic application
AU2935897A (en) Corrosion resistant, weldable coating compositions
AU4493496A (en) Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists
CA2149164A1 (fr) Compose insecticide a base de diatomite
FR2708976B1 (fr) Embout d'articulation de cardan.
EP0664442A3 (fr) Débitmètre à torsion.
MY112485A (en) Polyacetal resin composition
CA2322229A1 (fr) Compositions renfermant de l'heparine et recepteurs solubles du tnf pour inhiber l'activite du tnf
EP1035159A3 (fr) Compositions organopolysiloxanes antibactérielles et résistantes aux moisissures

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97193663.3

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF

ENP Entry into the national phase

Ref document number: 2247041

Country of ref document: CA

Ref document number: 2247041

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/1998/006760

Country of ref document: MX

Ref document number: 1997905227

Country of ref document: EP

Ref document number: 1019980706591

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1997905227

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1019980706591

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1997905227

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1019980706591

Country of ref document: KR